BRM Group
BRM Group, established in 1988, is a Tel Aviv-based private equity firm specializing in early-stage investments. It focuses on sectors such as life sciences, healthcare, consumer goods, and technology, with a particular interest in fintech, consumer, medtech, and enterprise companies. The firm aims to build diverse investment portfolios, primarily in the digital and internet sectors.
Innoventric
Series B in 2024
Innoventric is a medical device company based in Ness-Ziona, Israel, focused on developing innovative percutaneous solutions for Tricuspid Regurgitation and right heart disease. Founded in 2017, the company has made significant advancements with its Trillium™ technology, designed to provide functional tricuspid valve replacement through cross-caval anchoring and a unique multi-valve design. This technology aims to regulate blood flow effectively, thereby enhancing both the lifespan and quality of life for patients. Innoventric has successfully completed over ten implantations of the Trillium™ technology as part of its first clinical trial in Europe and maintains a robust patent portfolio covering its key innovations in tricuspid treatment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.